|
|
6-Methyl-and 1,6-dimethyl-8.beta.-carbobenzyloxy-aminomethyl-10.alpha.-ergoline as inhibitors of prolactin secretion
What is claimed is: 1. A method of inhibiting prolactin secretion in a female mammal in need of such therapy which comprises administering to the mammal an effective ...
|
|
|
Vinylazoles and their use for controlling fungi
We claim: 1. Vinylazoles of the formula ##STR4## where R is alkyl of 1 to 7 carbon atoms, phenyl or halogen-substituted phenyl where the double bond occupies position b ...
|
|
|
Flavone derivatives
I claim: 1. A compound of the formula ##STR9## wherein R.sub.1 and R.sub.2 are both methyl or ethyl or taken together with the nitrogen atom to which they are attached ...
|
|
|
Decyl quaternary ammonium compounds
The invention claimed is: 1. A quaternary ammonium compound having the structural formula ##STR4## wherein R is a lower alkyl group of from 1 to 4 carbon atoms, and X is ...
|
|
|
3-Oxomethyl-2-(1-nitro-2-oxoethylidene)-tetrahydro-2H-1,3-thiazines
I claim as my invention: 1. A compound of the forumla: ##STR4## wherein X and Y each is R, R--O-- or R--S--, R containing up to 30 carbon atoms and being alkyl, alkenyl, ...
|
|
|
Combating pests with 2-carboxymethyl-3-carboxy-chromones and esters
What we claim is: 1. A compound of the formula ##STR12## in which R is chlorine or methoxy, and R.sup.3 is hydrogen or methyl. 2. A compound according to claim 1 wherein ...
|
|
|
Carbamates of ergolines
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. D-6-methyl-8.beta.-(N,N-dimethylcarbamoylmethyl)-9,10-...
|
|
|
N-Aryl-N-(1-L-4-piperidinyl)arylacetamides
We claim: 1. A chemical compound selected from the group consisting of an N-aryl-N-(4-piperidinyl)arylacetamide having the formula: ##STR105## and the pharmaceutically ...
|
|
|
Method of treating helminthiasis by parenteral administration of sulfoxide derivatives of benzimidazoles
What is claimed is: 1. A method of treating helminthiasis, which comprises parenterally administering to a mammalian host an effective amount of a compound of the ...
|
|
|
Process for preparing 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
What is claimed is: 1. A process which comprises contacting an acid addition salt of a compound of the formula: ##STR105## wherein Y is halogen, with an aqueous alkaline ...
|